BioOrbit, founded in 2023, is a UK-based start-up and space manufacturing company aiming to develop pharmaceutical factories in space. They are focused on leveraging microgravity for the large-scale crystallization of protein drugs, particularly for cancer immunotherapy, with the goal of enabling subcutaneous injection and improving patient access to treatments. BioOrbit is currently developing hardware for efficient protein drug crystallization and aims to partner with pharmaceutical companies and researchers, and has a scheduled launch with The Exploration Company for Q2 2025. The company has also received funding from 7percent Ventures.
All verified mentions of this organization in source documents.
BioOrbit will use its UK Space Agency funding to design an end-to-end drug manufacturing mission in microgravity.
BioOrbit is a United Kingdom-based company developing a space-based pharmaceuticals factory.